MedPath

Transfer and Ultrafiltration In Peritoneal Dialysis

Not Applicable
Terminated
Conditions
End-stage Renal Disease
Registration Number
NCT02474719
Lead Sponsor
Centre Hospitalier Universitaire de Besancon
Brief Summary

The aim of this study is to demonstrate the efficiency of an adapted and "alternate" peritoneal dialysis scheme in terms of sodium extraction and purification compared to an adapted conventional peritoneal dialysis scheme.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
17
Inclusion Criteria
  • Patients hospitalized in the Nephrology department of the Besançon University Hospital
  • Patients treated by continuous ambulatory peritoneal dialysis or ambulatory peritoneal dialysis for at least 6 months
  • Absence of hospitalization caused by an infection in the month prior to inclusion
  • Patients with a ratio (D / P) of the concentration of creatinine in the blood and dialysate between 0.5 and 0.8 on a checkup of less than 1 year.
  • No contraindication to the use of hypertonic bag
  • Signature of informed consent for participation indicating that the subject has understood the purpose and procedures required by the study and agrees to participate in the study and comply with the requirements and limitations inherent in this study
  • Affiliation to a French social security system or beneficiary
Exclusion Criteria
  • Legal incapacity or limited legal capacity
  • Patients unlikely to cooperate in the study and/or low cooperation anticipated by the investigator
  • Patients without health insurance
  • Pregnant women
  • Patient being in the exclusion period from another study or planned by the "national register of volunteers"
  • Hospitalization caused by an infection in the month prior to inclusion
  • Patients with a peritoneal dialysis catheter dysfunction

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Intra-dialytic concentrations of different electrolytes (sodium, phosphorus, urea, creatinine, glucose and proteins)In a maximum of 72 hours after collection
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Besançon University Hospital, Nephrology Department

🇫🇷

Besançon, Franche-Comté, France

Besançon University Hospital, Nephrology Department
🇫🇷Besançon, Franche-Comté, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.